1. Home
  2. BXP vs DVA Comparison

BXP vs DVA Comparison

Compare BXP & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BXP
  • DVA
  • Stock Information
  • Founded
  • BXP 1970
  • DVA 1994
  • Country
  • BXP United States
  • DVA United States
  • Employees
  • BXP N/A
  • DVA N/A
  • Industry
  • BXP Real Estate Investment Trusts
  • DVA Misc Health and Biotechnology Services
  • Sector
  • BXP Real Estate
  • DVA Health Care
  • Exchange
  • BXP Nasdaq
  • DVA Nasdaq
  • Market Cap
  • BXP 11.6B
  • DVA 12.6B
  • IPO Year
  • BXP 1997
  • DVA 1995
  • Fundamental
  • Price
  • BXP $74.07
  • DVA $169.99
  • Analyst Decision
  • BXP Buy
  • DVA Hold
  • Analyst Count
  • BXP 15
  • DVA 5
  • Target Price
  • BXP $81.67
  • DVA $153.40
  • AVG Volume (30 Days)
  • BXP 1.1M
  • DVA 607.3K
  • Earning Date
  • BXP 01-28-2025
  • DVA 02-11-2025
  • Dividend Yield
  • BXP 5.30%
  • DVA N/A
  • EPS Growth
  • BXP 87.61
  • DVA 41.03
  • EPS
  • BXP 2.30
  • DVA 9.24
  • Revenue
  • BXP $3,344,005,000.00
  • DVA $12,666,614,000.00
  • Revenue This Year
  • BXP N/A
  • DVA $6.18
  • Revenue Next Year
  • BXP $1.62
  • DVA $3.58
  • P/E Ratio
  • BXP $31.83
  • DVA $18.37
  • Revenue Growth
  • BXP 4.47
  • DVA 6.34
  • 52 Week Low
  • BXP $56.46
  • DVA $103.40
  • 52 Week High
  • BXP $90.11
  • DVA $170.19
  • Technical
  • Relative Strength Index (RSI)
  • BXP 49.20
  • DVA 73.32
  • Support Level
  • BXP $71.59
  • DVA $151.10
  • Resistance Level
  • BXP $73.04
  • DVA $154.05
  • Average True Range (ATR)
  • BXP 1.66
  • DVA 3.48
  • MACD
  • BXP 0.43
  • DVA 2.06
  • Stochastic Oscillator
  • BXP 86.42
  • DVA 98.64

About BXP Boston Properties Inc.

BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

Share on Social Networks: